How ConcertAI is Revolutionizing Cancer Research with AI with Jeff Elton, CEO of ConcertAI

Outcomes Rocket

コンテンツは Saul Marquez によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャストコンテンツは、Saul Marquez またはそのポッドキャストプラットフォームパートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal。

3M ago 23:30

MP3•エピソードのホーム

Data integration and AI play crucial roles in predicting and managing treatment resistance in diseases like cancer.

In this episode, Jeff Elton, CEO of ConcertAI, discusses his team’s focus on oncology and its role in accelerating medical research and improving patient care. He highlights the importance of data integration and AI in understanding diseases like cancer, particularly in predicting and managing treatment resistance. Jeff explains how ConcertAI's technology enables real-time analysis of patient data, aiding in clinical decision-making and trial matching, and delves into setbacks faced in developing AI models, emphasizing the need for transparent and reliable algorithms in healthcare. He also underscores the evolving nature of the workforce in the age of AI, where high-skilled individuals will be essential for leveraging advanced technologies effectively.

Tune in and learn how ConcertAI is shaping the future of healthcare with AI-driven solutions!

Resources:

Watch the entire interview here.
Follow and connect with Jeff Elton on LinkedIn.
Learn more about ConcertAI on their LinkedIn and website.
Browse ConcertAI’s blog here.
Learn more about ConcertAI’s podcast here.